Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Retrospective Analysis of the Efficacy of Triplet Therapy, Including Lenalidomide, in Newly Diagnosed Multiple Myeloma Patients Who Obtained Responses Less Than VGPR after Rd Therapy

Naoki Takezako, MD PhD, Naoya Kaneko, MD, Airi Hamano, Ph, Kenichi Ito, MD, Naohiro Sekiguchi, MD, Satoshi Noto, MD, Takanori Teshima, MD

Blood (2019) 134 (Supplement_1): 5595.

https://doi.org/10.1182/blood-2019-131617

Published: 2019

Journal Articles

Recombinant Human Thrombomodulin in the Treatment of Acute Myeloid Leukemia Patients Complicated By Disseminated Intravascular Coagulation: Results of a Multicenter, Retrospective Epidemiologic Study in Japan

Naoki Takezako, MD PhD, Naohiro Sekiguchi, MD PhD, Satoshi Noto, MD, PhD, Yoshitaka Ogino, MD, Akiyoshi Miwa, MD PhD, Takayuki Ikezoe, MD PhD

Blood (2014) 124 (21): 2875.

https://doi.org/10.1182/blood.V124.21.2875.2875

Published: 2014

Journal Articles

Subcutaneous Injection Of Bortezomib, Combined With Doxorubicin and Dexamethasone (sPAD) Is Effective and Safety Induction Therapy For Untreated Multiple Myeloma Patients

Naoki Takezako, MD, PhD, Naohiro Sekiguchi, M.D., Ph.D., Akihisa Nagata, MD, PhD, Tsuyoshi Hagino, MD, PhD, Satoshi Noto, M.D., Ph.D., Kazuhiko Natori, M.D., Ph.D., Akiyoshi Miwa, MD, PhD

Blood (2013) 122 (21): 5391.

https://doi.org/10.1182/blood.V122.21.5391.5391

Published: 2013

Journal Articles

ST2 Utilizes Distinct Pathways to Suppress Inflammatory Cytokine Production and Modulate Rapid Differentiation of Human Monocytes Into CD83 + Dendritic Cells.

Naoki Takezako, MD, PhD, Naohiro Sekiguchi, M.D., Ph.D., Akihisa Nagata, Takeshi Hagino, Satoshi Noto, M.D., Ph.D., Akiyoshi Miwa, MD

Blood (2012) 120 (21): 2133.

https://doi.org/10.1182/blood.V120.21.2133.2133

Published: 2012

Journal Articles

Recombinant Human Thrombomodulin in the Treatment of Acute Myeloid Leukemia Patients Complicated by Disseminated Intravascular Coagulation: Retrospective Analysis of the Outcomes Between the Patients with Heparin and with Recombinant Human Thrombomodulin Therapy

Naoki Takezako, MD, PhD, Naohiro Sekiguchi, M.D., Ph.D., Akihisa Nagata, Satoshi Noto, M.D., Ph.D., Akiyoshi Miwa, M.D.

Blood (2011) 118 (21): 1247.

https://doi.org/10.1182/blood.V118.21.1247.1247

Published: 2011

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Retrospective Analysis of the Efficacy of Triplet Therapy, Including Lenalidomide, in Newly Diagnosed Multiple Myeloma Patients Who Obtained Responses Less Than VGPR after Rd Therapy

Recombinant Human Thrombomodulin in the Treatment of Acute Myeloid Leukemia Patients Complicated By Disseminated Intravascular Coagulation: Results of a Multicenter, Retrospective Epidemiologic Study in Japan

Subcutaneous Injection Of Bortezomib, Combined With Doxorubicin and Dexamethasone (sPAD) Is Effective and Safety Induction Therapy For Untreated Multiple Myeloma Patients

ST2 Utilizes Distinct Pathways to Suppress Inflammatory Cytokine Production and Modulate Rapid Differentiation of Human Monocytes Into CD83 + Dendritic Cells.

Recombinant Human Thrombomodulin in the Treatment of Acute Myeloid Leukemia Patients Complicated by Disseminated Intravascular Coagulation: Retrospective Analysis of the Outcomes Between the Patients with Heparin and with Recombinant Human Thrombomodulin Therapy

Email alerts

ASH Publications

American Society of Hematology

Update search

Retrospective Analysis of the Efficacy of Triplet Therapy, Including Lenalidomide, in Newly Diagnosed Multiple Myeloma Patients Who Obtained Responses Less Than VGPR after Rd Therapy

Recombinant Human Thrombomodulin in the Treatment of Acute Myeloid Leukemia Patients Complicated By Disseminated Intravascular Coagulation: Results of a Multicenter, Retrospective Epidemiologic Study in Japan

Subcutaneous Injection Of Bortezomib, Combined With Doxorubicin and Dexamethasone (sPAD) Is Effective and Safety Induction Therapy For Untreated Multiple Myeloma Patients

ST2 Utilizes Distinct Pathways to Suppress Inflammatory Cytokine Production and Modulate Rapid Differentiation of Human Monocytes Into CD83 + Dendritic Cells.

Recombinant Human Thrombomodulin in the Treatment of Acute Myeloid Leukemia Patients Complicated by Disseminated Intravascular Coagulation: Retrospective Analysis of the Outcomes Between the Patients with Heparin and with Recombinant Human Thrombomodulin Therapy

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only